Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05276024

Evaluation of the IFuse Bedrock Technique in Association with Posterior Lumbosacral Fusion with Iliac Fixation.

The purpose of this study is to describe the impact of the iFuse Bedrock technique to decrease post-operative pains in patients who underwent multilevel posterior lumbosacral fusion.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sacroiliitis Arthritis Joint Diseases Lumbosacral; Fusion Musculoskeletal Diseases Sacroiliac; Fusion Spine Deformity

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

Loading trial locations.

About this study

This study is a multicentric, post-marked clinical investigation to assess the efficacy of the iFuse Bedrock technique to avoid post-operative pains in patients who underwent open posterior multilevel lumbosacral fusion. Subjects will be monitored for lumbar pains (Oswestry score, VAS, SF-12 questionnaire) and sacroiliac joint pains (provocative tests) up to 12 months after initial procedure. A single CT-scan acquisition will be performed at 12 months to detect any iFuse system-related abnormality (implants loosening or breakages).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject scheduled for open posterior lumbosacral arthrodesis (including at least the following three vertebrae: L4, L5 and S1) associated with a sacroiliac fusion procedure and iliac fixation (thoracolumbar fusion procedures extended to sacrum are eligible in the study);
  • Insertion of at least 1 iFuse-3D implant according to the iFuse Bedrock technique (uni- and bilateral insertion are eligible);
  • Subject who preoperatively responded positively to pain provocation tests for SIJ dysfunction with or without a positive SIJ infiltration test;
  • Patient with a degenerative sacroiliac joint disease requested a fusion procedure;

Exclusion criteria

  • Major osteoporosis (DEXA scan > 3);
  • Any previous history of sacroiliac joint fusion or any surgical procedure involving a S2-iliac fusion;
  • Subjects requested a SIJ fusion without the iFuse-3D device or iFuse-3D not inserted according to the manufacturer instruction (Bedrock technique);
  • Subjects with a medical or surgical contraindication preventing the intervention from being performed or potentially interfering in the interpretation of the data collected (neurologic condition, local or systemic infection, any known allergy to surgical implants, psychiatric diseases, ...);
  • Currently pregnant or planning pregnancy;
  • Prisoner or a ward of the state;
  • Subject no willing to participate in the study;
  • Subject not affiliated to a social security insurance.

Treatment and study plan

iFuse Bedrock technique

Device

Lumbosacral arthrodesis on 2 or more spinal segments (including at least L4, L5 and S1 vertebrae) associated with a sacroiliac fusion procedure according to the Bedrock technique using the iFuse 3D system and iliac fixation.

Primary outcomes

  1. Change from baseline in self-reported Oswestry Disability Index (ODI) at 12 months

    Time frame: 12 months

    A decrease of 16 points in the ODI score at 12 months compared to the preoperative score is expected in order to demonstrate a 30% effecacy of the iFuse Bedrock technique in reducing postoperative pain.

Secondary outcomes

  1. Change from baseline in sacroiliac joint pain provocation tests.

    Time frame: During 12 months

    The number of positive SIJ pain provocation tests (Östgaard test, Faber test, Gaenslen test, Lasegue test, Compression, Long ligament test) performed at 3, 6 and 12 months will be compared against baseline (preoperative).

  2. Assessment of the Oswestry Disability Index

    Time frame: 3 and 6 months

    Change from baseline in self reported Oswestry Disability Index (ODI) score at 3 and 6 months.

  3. Improvement of back and leg pains at 3, 6 and 12 months compared to preoperative scores

    Time frame: 3, 6 and 12 months

    Back and leg pain intensity self-report will be assessed before and after initial procedure for each patient (at 3, 6 and 12 months) using a 0 to 10 visual analog scale (0: no pain ; 10: most imaginable pain).

  4. Change in Patient's quality of life

    Time frame: 3, 6 and 12 months

    Change from baseline in self reported 12-Item Short Form Survey (SF-12) score at 3, 6 and 12 months.

  5. Proportion of subjects with postoperative SIJ fusion failure

    Time frame: 12 months

    Proportion of subjects with SIJ fusion failure on CT scan as interpreted by the investigator

  6. Impact of iFuse Bedrock technique on Pelvic Incidence

    Time frame: During 12 months

    Measurement of postoperative Pelvic Incidence (PI) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Pelvic Incidence is the angle between the line perpendicular to the S1 endplate from the midpoint of the endplate and the connecting line from the midpoint of the S1 endplate to center of the femoral head.

  7. Impact of iFuse Bedrock technique on Pelvic Tilt

    Time frame: During 12 months

    Measurement of postoperative Pelvic Tilt (PT) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Pelvic Tilt is the angle between the connecting line from the midpoint of the S1 endplate to the center of the femoral head and the vertical line.

  8. Impact of iFuse Bedrock technique on Sacral Slope

    Time frame: During 12 months

    Measurement of postoperative Sacral Slope (SS) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Sacral Slope is the angle between the tangent and the horizontal line of S1 endplate.

  9. Impact of iFuse Bedrock technique on Lumbar Lordosis

    Time frame: During 12 months

    Measurement of postoperative Lumbar Lordosis (LL) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Lumbar Lordosis is the angle between the L1 upper endplate and the S1 upper endplate.

  10. Impact of iFuse Bedrock technique on Thoracic Kyphosis

    Time frame: During 12 months

    Measurement of postoperative Thoracic Kyphosis (TK) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Thoracic Kyphosis is the angle between the T4 upper endplate and the T12 lower endplate.

  11. Impact of iFuse Bedrock technique on the Odontoid Hip Axis

    Time frame: During 12 months

    Measurement of postoperative Odontoid Hip Axis (OD-HA) using EOS stereography at 3, 6 and 12 months compared to baseline.

    Odontoid Hip Axis is the angle between the vertical and the highest point of the odontoid process (dens) connecting to the centre of the acetabulum (bi-coxo-femoral axis)

  12. Impact of iFuse Bedrock technique on the T1 pelvic angle

    Time frame: During 12 months

    Measurement of postoperative T1 pelvic angle (TPA) using EOS stereography at 3, 6 and 12 months compared to baseline.

    TPA is the angle between the line from centroid of T1 to the femoral head axis and the line from femoral head axis to middle of the S1 endplate

  13. Proportion of subjects with iFuse-3D implant-related complications

    Time frame: 12 months

    Proportion of subjects with any of the following complications related to the iFuse-3D implant : malposition of the implant (intra-operative evaluation), loosening, displacement, abnormal bone reaction, breakage or any other complication directly related to the insertion or use of the iFuse-3D implant.

  14. Incidence of any serious adverse events

    Time frame: During 12 months

    Record of any intra and postoperative complications

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa Boue

CONTACT

[email protected]

+33(0)556437017

Stéphane Bourret

CONTACT

[email protected]

+33(0)556437017

Sponsors and collaborators

Lead sponsor

Polyclinique Bordeaux Nord Aquitaine

Other

Collaborators

  • SI-BONE, Inc.

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Mar 11, 2022
Registry last updated
Nov 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.